Timothy Hagen is currently a Professor of Chemistry at Northern Illinois University. Prior to NIU, Tim worked in the pharmaceutical industry as a synthetic organic and medicinal chemist for more than 20 years. He worked for Searle, Pharmacia and Pfizer (all the same company through multiple mergers), and deCODE. He is an author on 35 journal articles, an inventor on 42 patents and patent applications, and a contributing author to three books.One of the compounds he worked on at Pfizer, SD-6010, is currently in Phase II clinical trials for the treatment of osteoarthritis.

Research interests of Timothy Hagen laboratory are at the interface of chemistry and biology. The focus is on structure-based design and synthesis of small molecules that can modulate essential pathways of infectious disease organisms with an emphasis on small molecule-protein interactions and target specificity. The laboratory utilizes fragment-based screening, de novo design, the design and synthesis of versatile fragment building blocks from natural products, and construction of fragment libraries to explore enzyme selectivity.

Dr. Amy K Sater is an Associate Professor in the Department of Biology and Biochemistry at the University of Houston. She has received her PhD. at the University of Texas at Austin and carried out postdoctoral studies at the University of California, Berkeley. She has authored 33 research articles and 3 book chapters, and she co-edited Analysis of Growth Factor Signaling in Embryos (CRC Press). She has served on the Xenopus Genome Steering Committee since 2005, and she co-organizes the “Cell and Developmental Biology of Xenopus” course at Cold Spring Harbor Laboratory (2011-2013). She is a member of the Society for Developmental Biology.

My chief research interests lie in the mechanisms that govern early vertebrate development. Much of our work examines aspects of signaling, and we have ongoing interests in transcriptional and post-transcriptional gene regulation. We are currently investigating the roles of microRNA-dependent regulation during the establishment of embryonic cell fate. These studies are conducted using the amphibian Xenopus; Xenopus embryos offer a unique opportunity to integrate analyses of gene function during vertebrate development with studies of biochemical and molecular mechanisms. A second major interest is genomics and the establishment of genomics resources for Xenopus.

Xu-Rong Jiang, PhD MD, is an Associate Director in Analytical Biochemistry at MedImmune, LLC, a biologic subdivision of AstraZeneca.  Dr. Jiang had previously been a Principal Scientist in Process & Analytical Sciences at Amgen Inc. where he led a group of scientists to develop, qualify and validate potency assays for clinical and commercial protein products. Dr. Jiang’s particular areas of interest are cell-based assays using genetically engineered cell lines, receptor binding assays, and rapid readout assays.  Prior to Amgen, Xu-Rong was a Senior Scientist at Geron Corporation focused on gene therapy and cell therapy, high throughput screening and developing regenerative medicine techniques.   Dr. Jiang did post-doctoral work at the University of London and received his Ph.D. from St. Bartholomew’s and Royal London Hospital School of Medicine, University of London.  He has published more than 20 journal papers and is an assignee of three U.S. patents.
 

Dr. Jiang’s particular areas of interest are cell-based assays using genetically engineered cell lines, receptor binding assays, and rapid readout assays

Professor Thomas Efferth is chair of the Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemsitry, University of Mainz, Mainz, Germany.  He is biologist by training and obtained his degree from the Technical University of Darmstadt, Germany. His doctoral thesis was completed at the German Cancer Research Center, Heidelberg, Germany, in 1990. Dr. Efferth was awarded the Ludolf-Krehl-Prize of the Southwest German Association for Medicine in 1991 and the Willmar-Schwabe-Award of the German Society for Medicinal Plant Research in 2006. From 2005-2009 he headed a research group for Pharmaceutical Biology at the German Cancer Research Center, Heidelberg, Germany. From 2007-2009 he was associate professor  at the University of Heidelberg. In 2009, he took over the Chair of Pharmaceutical Biology  at the University of Mainz. Furthermore, he is honorary professor at the Northeast Forestry University, Harbin, China and visiting professor at the Zhejiang Chinese Medical University, Hangzhou, China. Thomas Efferth has published over 200 original papers and over 80 reviews in peer-reviewed journals in the field of cancer research, pharmacology, and pharmacogenomics and natural products. He holds four patents. The scientific results were communicated in over 120 oral presentation and invited lectures and over 100 poster presentations at national and international conferences and meetings. A textbook on Molecular Pharmacology and Toxicology written by him appeared in 2006. He is co-editor and editorial board member of 13 scientific journals and scientific advisory board member of several institutions.

The focus of Dr Efferths research is on tumor pharmacology and the development of novel options for treatment and diagnosis of cancer. A major topic is research on natural products derived from medicinal plants. Two fields are in the center of his interest
1. Molecular pharmacology and toxicology of natural products. Drug resistance and severe side effects represent major obstacles of current chemotherapy. This necessitates the identification of novel compounds from plants with anticancer activity. The aims are a. the identification of novel drugs with improved tumor specificity and efficacy against drug-resistant tumors as well as less adverse side effects and b.  the analysis of underlying molecular modes of action in tumor cells and normal tissues. A current research project focuses on chemically pure compounds derived from medicinal plants and their analysis by systems biology

2. Genome-wide expression profiling and genomic aberrations in tumors. Drug resistance of tumor cells reduces the probability for patients to be cured and reduce survival. The knowledge of determinants which affect drug responsiveness of tumors and prognosis of patients would allow the design tailor-made treatment protocols for each individual patient. The aim is to develop techniques for the predictive determination for individualized therapy options and the implementation of natural products for treatment. The overall aim is the integration of active principles of traditional Chinese medicine into western medicine.
 

Prof. Aurel Popa-Wagner has received his PhD in Biochemistry at Institute of Biochemistry, University of Karlsruhe, Germany during the period of: 1988-1990. Currently, he is working as Professor of Experimental Neurology at the Department of Neurology and Head of the Research Department of the Ernst-Moritz-Arndt University, Greifswald, Germany; Professor of Pathobiochemistry and Director of the Department of Molecular Medicine, University of Medicine and Pharmacy, Craiova, Romania. He has successfully completed his Administrative responsibilities as Coordinatorof (i) Neuroscience Research Programme at the Medical Faculty, Ernst-Moritz-Arndt University, Greifswald, Germany; (ii) of the programme “Molecular imaging in aging and neural repair” at the Medical Faculty, Ernst-Moritz-Arndt University, Greifswald, Germany. He is serving as an editorialmemberofseveralreputedjournalslike: Oxidative Medicine and Cellular Longevity and BMC Geriatrics. He has authored 70 research articles/books. He is a member of: German Society for Aging Research; The Society fo the Study of Neuroprotection and Neuroplasticity-International Board. He has honored as: Rene Schubert Prize for Research on Ageing.

The aim of Aurel Popa Wagner group is to unravel cellular and molecular mechanisms underlying aging progression and its significance for brain diseases. The group has a long-standing interest in molecular mechanisms of brain remodelling in the aged rat brain. His group has studied the plasticity of the aging brain in response to stimuli for more than 15 years and to stroke injury in aged animals for the last 10 years. Overall our results suggest that: (1) although older animals retain the potential for brain plasticity-related cytogenetic events after injury, the expression of key brain plasticity-associated genes and proteins is often attenuated and temporally altered; (2) an important cellular event associated with restricted axonal growth after stroke in aged animals is the early formation of a scar in the infarcted region; (3) Granulocyte-Colony Stimulating Factor lowers mortality and enhances neurogenesis in the brains of post-stroke aged animals; (4) vascular wall reactivity is exacerbated in the post-stroke aged animals. Expertise: aged animals models of cerebral ischemia; behavioral analysis; recording of EEG and various physiological parameters by telemetric measurements; MRI for small animals; immunohistochemical procedures, proteomics, genomics.

Edward Lai obtained his Ph.D. degree in Analytical Chemistry from the University of Florida (U.S.A.) in 1982. He is a Full Professor at Carleton University (since 1999) who has accumulated 29 years of research experience and knowledge in bioorganic and environmental analytical chemistry. He is a fellow of the Chemical Institute of Canada (since 2004), has published 102 scientific papers, and presented over 110 talks/posters at conferences. His research interests are instrumental analysis of biochemical and environmental samples, using new photochemical, electrochemical, chromatographic and electrophoretic techniques to develop new analytical methods for enhanced sensitivity and selectivity. He has a wealth of experience in synthesizing highly functional molecularly imprinted polymers (MIPs) for specific recognition of pharmaceuticals, mycotoxins, and endocrine disrupting compounds. He also teaches electronic instrumentation and automation at the graduate level.

Edward Lai research interests are Instrumental analysis of biochemical and environmental samples for public health, using nanosecond laser spectroscopy, surface plasmon resonance (SPR), capillary electrophoresis (CE), and liquid chromatography-mass spectrometry (LC-MS). New photochemical, electrochemical and optical phenomena are developed into analytical methods for enhanced sensitivity and selectivity: (a) SPR immunosensor for the detection of fumonisin B1 and peanut allergenic proteins in agricultural crops and food extracts; (b) molecularly imprinted polymers for the selective determination of therapeutic drugs in serum, ochratoxin A in red wine, and estrogenic compounds in waste water treatment by solid-phase extraction with differential pulsed elution; (c) laser desorption ionization for the TOFMS analysis of bioorganic molecules on polypyrrole-coated nanospheres; (d) self-assembled monolayers and electropolymerized thin films for adsorption of toxic metals (Hg2+, Ag+), radioactive nuclides (Sr-90, Y-90), and biomolecules (mycotoxins, peptides, proteins); (e) bioconjugation of quantum dots with proteins, antibodies and synthetic receptors; and (f) functionalization of superparamagnetic nanoparticles for removal of E. coli in water.

Duarte N da Silva Marques, DDS, PhD. Duarte Marques is currently a Assistant Professor of the Oral Biology and Biochemistry Department at the Dentistry Faculty of the University of Lisbon. He was awarded his PhD in Oral Physiology in 2008 at the University of Extremadura and the DDS in 2002 at the Instituto Superior de Ciências da Saúde Egas Moniz. He is an author and co-author of several peer review manuscripts in the area of oral biology and biochemistry, a researcher with one European patent and a contributing author to two books.

Duarte Marques research interests are Oral Biology and Biochemistry presently defines itself as the field of knowledge related to the study of chemical and biochemical behavior, structure, development and function of oral tissues and related structures and their relationship with other organ systems in health and disease. His group is focused in the salivary domain with a developed expertise along the years of research. His main research areas are saliva properties and dental erosion, the organic and inorganic modifications on enamel and dentin by bleaching products and salivary changes in HIV.

Boris Kurganov, was born in Lomonosov town on 27th June 1938. He is living in Moscow from 1943. During 1955-1960 he was a student of the chemical faculty of the Moscow State University and graduated from the University with a red diploma. From 1960 to 1964 he studied for Ph.D at the Moscow State University. From 1964 he was a Junior Research Associate in N.N. Semenov Institute of Chemical Physics of USSR Academy of Sciences. From 1968 to 1988 he worked in the Scientific-Industrial Association "Vitaminy"of Ministry of Medical Industry. In 1984 he was awarded the USSR State Prize in the field “Chemical basis of biological catalysis”. From 1989 he is working in Bach Institute of Biochemistry of Russian Academy of Sciences where he is a Head of Laboratory of Enzyme Systems. He is a member of Editorial Boards of “Biochemistry (Moscow)”, “Applied Biochemistry and Microbiology” and Medline.

Boris Kurganov research interests are protein stability, protein denaturation and aggregation, Protein folding and misfolding, Protein refolding, Chaperones (including chemical chaperones), Molecular crowding, Enzyme kinetics, Allosteric enzymes, Enzymes of glycogen metabolism, Protein dissociation and association,  Differential scanning calorimetry, Dynamic light scattering.
 

Dr. Ramana is an Associate Professor at Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX-USA. The chief objective of his investigations is to examine the involvement of cellular metabolism and oxidative stress signals in inflammation and to delineate the role of aldo-keto reductases in the inflammatory pathways.  He uses various genetic, biochemical and cell biological approaches to analyze inflammatory responses regulated by cellular metabolites in various inflammatory pathologies such as sepsis, uveitis, asthma and cancer. He has published 70 peer reviewed articles. He is also serving as an editorial board member of 7 other journals and reviewer of several journals.

Dr. Ramana research interests are Cellular metabolites mediated signal transduction pathways; Oxidative stress signaling in inflammatory complications; Role of polyol pathway enzymes in inflammatory pathologies.

Prof. Giuseppe Lazzarino has received his Degree in Biological Sciences at the State University of Rome "La Sapienza", Rome, Italy in 1979. In 1980 he joined an Italian pharmaceutical company, becoming head of the Biochemistry and Pharmacology Research Laboratory. In 1986 he became Researcher in Biochemistry at the University of Rome "Tor Vergata", Rome, Italy. Since 1994 he is Full Professor of Biochemistry at the School of Biology of the University of Catania, Catania, Italy. During his collaborations with different groups he spent periods at the University of Oulu, Finland (Prof. Hassinen and Prof. Nuutinen), the Webb-Waring Institute for Biomedical Research, Denver, Colorado, USA (Prof. J.M. McCord), the University of Texas, Austin, USA (Prof. J.W. Starnes) and the University of Missouri, Columbia, USA (Prof. M.J. Rovetto and Prof C.H. Hardin) doing research and giving seminars and lectures. Since the end of 2010 he established a spin-off company aimed to perform metabolic screenings of biological fluids for prenatal and postnatal diagnosis of IEM, as well as to evidence biochemical markers of clinical interests. He is an author of more than 90 papers (both original articles and reviews) in the field of biochemistry and, mostly, of translational medicine (neurotraumatology, neurology, cardiology). He holds 4 patents.

Biochemistry, clinical biochemistry and translational medicine are the main areas of interest in prof. Giuseppe Lazzarino laboratory. In particular, he has interested in studying: 1) biochemical and metabolic changes in traumatic brain injury (both in rats and human beings); 2) energy metabolism and free radical damage in animals and human beings; 3) biochemical markers of clinical relevance in different pathological states (neurodegeneration, myocardial ischemia, etc.); 4) biochemical and molecular evaluation of IEM (inborn errors of metabolism ); 5) metabolic screenings for the prenatal diagnosis of IEM.

Prof. Luis Eduardo Quintas is a biochemical pharmacologist in the Institute of Biomedical Sciences at Federal University of Rio de Janeiro. He has received his PhD in Pharmacology/Biophysics in 2001 and did postdoctoral training in University of Toledo, USA, working on P-type ATPases, especially Na/K-ATPase, and currently investigates the pathophysiological regulation of ATPases and the effect of cardiotonic steroids on Na/K-ATPase-mediated signaling transduction. He also integrates the Program of Pharmacology and Medicinal Chemistry aiming at the pharmacological screening and development of new drug candidates.

Prof. Luis Eduardo Quintas research interests are Pathophysiological regulation of P-ATPases; Cardiotonic steroid-induced Na,K-ATPase-mediated signaling transduction cascades and cellular effects; Pharmacological screening of novel drug candidates.

Dr. Chung received Ph.D at Baylor College of Medicine. He characterized biochemical properties of the novel adenovirus oncoprotein, E4-ORF1. Dr. Chung moved to Wisconsin, where he did his postdoctoral training at McArdle Laboratory for Cancer Research, University of Wisconsin. He determined a molecular mechanism by which estrogen cooperates with human papillomavirus (HPV) oncogenes to promote cervical cancer. He also identified hormonal drugs that are efficient in treating cervical cancer using HPV transgenic mouse model. Chung lab is interested in further defining mechanisms by which hormone receptors modulate cervical carcinogenesis and HPVgene expression.

Our research interests are:
1. Roles of hormones in HPV-induced cancer
2. Roles of hormones in HPV replication

Dr. Abdalla El-Mowafy has received  Postdoctoral fellowship from Dept. Physiology, School of Medicine, WSU, Ohio, USA (1997-1999) & PhD in Biochemical pharmacology (1995) at the Medical College of Georgia, USA (Channel joint-supervision system). Currently he is working as Professor of Biochemistry/Pharmacology: Mansoura University (Egypt)- Kuwait University- Canadian University (Egypt)- MIU Univ (Egypt)- Jazan University (KSA). He is a Member of the Supreme Egyptian University promotion committee (Biochemistry). He is a Licensed Clinical Biochemist (since 1990),  Associate-editor (Nutrition & Metabolism) USA, Editorial board (Cardiovascular Diabetology) USA, Editorial Board (European J. of Cardiovascular Medicine) UK & Editorial Board Member (Biochem and Anal. Biochemistry).

Abdalla El-Mowafy research expertise is in Biochemistry, molecular pharmacology and signal transduction mechanisms of Cardiovascular disease, Cancer and Diabetes.

Prof. K.D. Gill received her Ph.D in Biochemistry from Punjab Agricultural University, Ludhiana, India during the period of 1970-1974. Currently she is working as Professor in the Department of Biochemistry, Post Graduate Institute of Medical Education and Research, Chandigarh 16002 India. She has authored more than 100 research publications. She is member of many national and international societies Viz Society of Biological Chemists, India, Association of Clinical Biochemists, India, Indian Academy of Neurosciences, India, Indian society for Pain Research and Therapy, Indian Science Congress, Society of Applied Biotechnology, Asian Pacific Society for Neurochemistry, American Association for the Advancement of Science and American Society for Neurochemistry. She has been honoured as Fellow of Sociaty of Applied Biotechnology, India.

Kiran Dip Gill research interests are molecular mechanisms involved in neuronal death in Parkinson’s and Alzheimer’s disease in cell culture and animal models, molecular basis of organophosphate and metal neurotoxicity which includes signal transduction pathways, apoptosis, receptor ligand binding, protein phosphorylation, peripheral markers, NTE isolation and characterization, neurobehavioral studies and Paraoxonase polymorphism. In addition to that her lab is also focusing on primary cell culture of neurons and microglia to understand the molecular targets of neuronal degeneration after exposure to organophosphates and heavy metals. An another area of interest is neuroprotection using various natural antioxidant and mitochondrial drug targeted delivery in vivo and in vitro systems.

Subrata Chattopadhyay research interests are
Organic Synthesis: Synthesis design of natural products and congeners, Development of new asymmetric reactions, Organometallic chemistry.
Natural Products: Natural radiomodifiers, anticancer agents and antiulcer drugs.
Biocatalysis: Non-aqueous Enzymology & microbial transformation, Enzymatic asymmetric reactions, Studies and modulation of enzyme topology, Bioremediation of organic and metallic wastes. Chemoenzymatic enantioselective syntheses.
Chemical Biology : Antioxidants and redox chemistry and biochemistry, Design of photo and radiosensitizers, Drug design for cancer and gastric ulcer therapy, New drug for nuclear medicine, Novel Material
Chemistry: Design of molecular hosts, Studies on supramolecular photoactive assemblies.

Dr. Zhongjun Zhou Graduated from China, he went to Sweden for PhD and Postdoc training in Karolinska Institute. In year 2003, he started his own lab in the University of Hong Kong in the Department of Biochemistry. His work has published in the leading journals such as Nature Genetics, Nature, Nature Medicine, Cancer Res, PNAS, JCB, JBC, BLOOD, Circ Res, Human Mol Genet, EMBO J etc. Since joining the University of Hong Kong, He has received the Outstanding Research Output Award, National Award for Scientific and Techmological Advance, 12 external research grants from Hong Kong, China and USA.

Dr. Zhongjun Zhou research focuses on development and diseases. He works on the understanding of aging processes and signalling regulations that controls development and diseases using mouse models. He is interested in how stem cells affect aging and how aging affects stem cells. He has been working on the molecular mechanism underlying the stem cell decline and signalling pathways that control the stem cells depletion in aging. He is also interested in how pericellular proteinase affects development.

Dr. Wang is an Associate Professor in the College of Science and Health Professionals at Albany State University. He earned his Ph. D in Theoretical Chemistry from Shandong University in 1994. He completed postdoctoral training at Max-Planck Institute for Physics of Complex System, and Texas A&M University. Dr. Wang has published 72 peer-reviewed journal articles, and has also co-edited one book and contributed to 4 book chapters. Dr. Wang’s expertise is in computational/theoretical chemistry with applications in molecular design of nano-material based drug delivery systems, noncovalent interactions of bio-nano systems, and molecular modeling and simulations of advanced power sources. As a PI, Dr. Wang’s research is currently supported by NIH, ARAA project, and ACS PRF. Dr. Wang’s awards include 2009 Research of the Year at Albany State University, State Natural Science Award (State Council of China, 1997).
 

Wang’s expertise is in computational/theoretical chemistry with applications in molecular design of nano-material based drug delivery systems, noncovalent interactions of bio-nano systems, and molecular modeling and simulations of advanced power sources. As a PI, Dr. Wang’s research is currently supported by NIH, ARAA project, and ACS PRF. Dr. Wang’s awards include 2009 Research of the Year at Albany State University, State Natural Science Award (State Council of China, 1997).

 

I started my career at Louisiana State University as a graduate student studying Rab GTPases in Dictyostelium under the direction of Dr. James Cardelli.  My thesis was specifically on RabD, a Rab14 mammalian homolog, but expanded into several of the participating Rabs and some of the lysosomal trafficking regulators such as Lvs. In 2002, I started a post-doc fellowship in the laboratory of Dr. Paul H. Weigel dissecting the biochemical relationship of the HARE/Stabilin-2 receptor with the binding and endocytosis of glycosaminoglycans, primarily hyaluronan and heparin. These studies resulted in 8 papers in which I and my colleagues examined how these ligands bind, how they are competed by each other, signaling mechanisms propagated by the receptor, and so forth. I spent 8 years in Oklahoma City; 4 years as a post-doctoral fellow and 4 years as a research assistant professor.  During this time I also taught nutritional biochemistry to the Food and Nutrition undergraduate and graduate students. In 2010, I started up my own lab at the University of Nebraska.
 

My primary research interest is in the continual study of the Stabilin receptors and how they bind different heparinoid polymers. This ranges from basic biochemical assays for binding/competition to using animal models to examine the physiological aspects of heparin, HA, chondroitin sulfate scavenging in the liver.  The body turns over approximately 1/3 of the total hyaluronan content daily.  Heparin, which is used in all surgical procedures and in the treatment of thrombosis and dialysis, is a very diverse molecule with little understanding of how it is catabolized from the blood stream. My lab seeks to understand how the liver scavenges heparinoid molecules and what other molecules may inhibit or enhance the initial steps in this catabolic pathway. Other interests include the host liver cell of the stabilin receptors which is the sinusoidal endothelial cell (SEC) and how it behaves under metabolic stresses such as dyslipidemia and fluxes of heparin and HA. There are also interesting cross-talk pathways between SECs and hepatocytes since SEC are the guardians of the liver. They contain fenestration or cytoplasmic holes in which they act as a filter for macromolecular complexes. SECs are among the most endocytic cells in the body and their ability to internalize and catabolize the myriad amount of material from the blood has not been fully explored.
 

Joshua Smith earned his PhD in analytical chemistry in 2007 at the University of Florida, and currently is an assistant professor of chemistry at Armstrong Atlantic State University in Savannah, GA.Smith received BS degrees in chemistry and mathematics and BSE degrees in chemistry and mathematics in 2002 from Clarion University of Pennsylvania in Clarion,P. He has published manuscripts, presented his research at national conferences, and has a patent on his work in bioapplications of nanotechnology.

Joshua Smith earned his PhD in analytical chemistry in 2007 at the University of Florida, and currently is an assistant professor of chemistry at Armstrong Atlantic State University in Savannah, GA.Smith received BS degrees in chemistry and mathematics and BSE degrees in chemistry and mathematics in 2002 from Clarion University of Pennsylvania in Clarion,P. He has published manuscripts, presented his research at national conferences, and has a patent on his work in bioapplications of nanotechnology.

Agrobacterium transformation and infection, developing new tools for molecular biology, gene cloning and manipulation, yeast two-hybrid system, plant tissue culture, confocal microscopy, protein-protein interactions .

Dr. Qin received a Masterraquo;s and MD from Xian Medical University with a specialization in dermatology, and his PhD from the Chinese Academy of Medical Sciences at Peking Union Medical College, with both his Masters and PhD in microbial infections, inflammation and hostpathogen interactions. He was a postdoctoral fellow for one year at the National Institute of Infectious Diseases in Atlanta, and a second 3year postdoctoral fellowship at Emory University Cardiology Division. He worked with Drs. Tohru Fukai and David Harrison to study the role of reactive oxygen species in cardiovascular disease. Before joining to UTHSCSA Division of Vascular Surgery as an Assistant Professor and a director of the Vascular Metallomics Research Laboratory, Dr. Qin also worked at the University of Cincinnati Division of Cardiovascular Disease for four years as a Research Instructor.

The driving force of Dr. Qin»s project is due to advances in techniques and science, it is time to revisit the vascular function of copper, an essential nutrient in human. First, the sensitivity and application of metallomic techniques have greatly improved. Dr. Qin is utilizing a highly novel approach that combines cutting-edge X-ray fluorescence spectrometric (XRF) imaging with inductively coupled plasma-mass spectrometry (ICP-MS) to detect copper concentrations and localization in the blood vessel wall. Application of XRF imaging to biological samples in 2004 represented one of most exciting advances in metallomics. Dr. Barry Lai at the Argonne National Laboratory collaborates with Dr. Qin to apply this technique in vascular study. In addition, the emerging flow injection technique along with improved sample extraction methodology has produced a more powerful ICP-MS. The technique has been optimized and applied in Dr. Qin project in vascular tissues and cells via a close collaboration with Dr. Joseph Caruso in the Department of Chemistry at the University of Cincinnati. Moreover, they established a novel concept, vascular metallomics, to bridge the gap between vascular biology and metallomics. Second, copper trafficking theory has been recently established and validated in several laboratories. This theory convincingly defines a group of proteins in the regulation of uptake, distribution, sequestration and export of copper. Among these proteins, ATP7A has attracted significant attention since the identification of its function as a copper egress pump and the discovery of mutations of ATP7A leading to human Menkes disease. Dr. Qin»s approach is to study the physiopathology of the interaction between cardiovascular homeostasis and copper metabolism in vascular biology via dissecting the function of ATP7A.

Guanyu Wang, physicist and biochemist. He received two PhDs: one is of engineering from Zhejiang University China in 1998; the other is of medical sciences from University of Cologne Germany in 2005. He worked as a postdoctoral fellow at University of Texas Health Science Center at Houston, School of Health Information 20002003; as a research assistant professor at Medical School of the same university 20032005; as a visiting scientist at Rice University 20052006. He then remains as an assistant professor at the Physics Department, George Washington University. His research interests are in the areas of biophysics and biochemistry, systems biology, and cancer. He applies nonlinear dynamics to study complex biochemical networks, and how the deregulation of such networks may lead to diseases. His researches have advanced our understanding of complex diseases such as cancer and diabetes.

•Biochemical networks
• Enzyme kinetics
•Systems biology
•Computational and Mathematical biology
• Complex diseases.

Some of my major findings involve life’s fundamental processes which include The demonstration that the binding of specific tRNA to the complex of ribosome and synthetic poly-nucleotides. This discovery formed the basis of genetic code determination. First description of the enzyme arginyl tRNA protein transferase (ATE1), which transfers arginine to proteins.ATE1 is now recognized as the key enzyme which plays an important role in protein function and degradation. Discovery that J chain which is an essential protein for the polymerization of polymer immunoglobulins(IgM and IgA) is produced even in cells which does not form polymers. Recent finding that the fourth step of protein synthesis, recycling of ribosomes in eukaryotes is catalyzed by a factor called eEF3 (eukaryotic elongation factor three).I also contributed a great deal to elucidation of the fourth step in prokaryotes catalyzed by ribosome recycling factor (RRF).

Masood-ul-Hassan Javed basic degrees (BSc, & MSc) are in Physiology, MPhil in Biochemistry & Molecular Biology and PhD in Biology (Physiology & Biochemistry). He has about 32 years teaching experience of Human Physiology & Biochemistry to the Medical, Pharmacy and Biology students. Masood-ul-Hassan Javed also taught Pharmacology (to pharmacy and medical students), Cell Biology (to biology and medical students) for about 6 years. Presently Javed is teaching Physiology & Histology and partly Biochemistry and Pharmacology to the Medical students at the Sulaiman Al Rajhi University in Bukaryiah, Saudi Arabia.

Masood-ul-Hassan Javed interest is in the Enzymes & proteins related to biomedical sciences and I have 57 publications. Javed had developed a very rapid method to de-stain proteins after PAGE. Javed hope this method will be highly useful for research. He intend to get its patent, therefore do not want to publish it yet.

Adam Lesner has born 1971. He achieved his MS in 1994 at Gdansk University, Gdansk, Poland. His PhD thesis titled Chromogenic substrates of bovine β-trypsin in 2001. From 2001 to 2004 he is in Virology Department of Columbia University NYC (USA), from 2004 back to Faculty of Chemistry Bioorganic Chemistry Department at Gdansk University (Poland). He is co-author of 40 original papers and more than 50 conference papers.

Adam Lesner Major interests are peptide synthesis, combinatorial chemistry and proteolysis, along with substrates and inhibitors of selected proteases.

Dr. Jun Ling has received his PhD in Biochemistry and Molecular Biology in 1994 from “Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences”. Currently, he is working as Assistant Professor at the Commonwealth Medical College, PA. He serves the duty on several administrative committees, including curriculum development, graduate student advisory and MD student application at the College. He served as an ad hoc reviewer for several journals, like “J. Biol. Chem.” and “Mol. Cell Biol.”. He is serving as a panel reviewer on “Bankhead-Coley Cancer Research Program, Florida Department of Health”. He has authored over 40 peer-reviewed research articles and book chapters. He is a member of “American Society for Biochemistry and Molecular Biology (ASBMB)” and “American Heart Association”. Dr. Ling has been honoured by the “Certificate of Recognition for Research and Scholarly contribution to TCMC” in 2009.

mRNA translation, signal transduction, cancer biology, transcriptional regulation, nuclear receptor, proteomics, label-free biophysical technique, and vaccine development.

Dr. Xiaoduo Fan is a Board certified staff psychiatrist at Massachusetts General Hospital MGH, and an Assistant Professor of Psychiatry at Harvard Medical School. Dr. Fan’s research interests focus on pharmacological interventions for refractory symptoms, cardiometabolic comorbidity and real life functioning in patients with schizophrenia.In addition, he is interested in cultural aspect of psychiatry, particularly mental health issues in Asian populations. Over the past several years, Dr. Fan has established research collaboration with Shanghai Mental Health Center in China. Dr. Fan has received several prestigious awards such as the National Institute of Mental Health NIMH Outstanding Resident Award, Future Leaders in Psychiatry Award and the NARSAD Young Investigator Award twice. More recently, Dr. Fan received a fiveyear Career Development Award from NIMH K23 to support his research in innovative treatment strategies for cognitive deficits and metabolic problems in patients with schizophrenia.

Dr. Xiaoduo Fan research interests are Innovative treatment strategies for cognitive deficits and metabolic problems in patients with schizophrenia.

Dr. Hua Dong got her PhD degree in Analytical Chemistry from Michigan State University in 2009. Her PhD work was mainly focused on the investigation of neural control mechanisms of arteries and veins, and how these mechanisms are altered in saltsensitive hypertension by probing neurotransmitter, norepinephrine, release from sympathetic nerves of mesenteric arteries and veins in vitro using electrochemical method. And she was awarded dissertation completion fellowship for the significant findings for her PhD work. She then moved to University of California at Davis to continue academic career as a post doctoral research associate. Her research involves metabolomics study in different types of inflammatory disease models, pharmacokinetics study for soluble epoxide hydrolase sEH inhibitors, and analytical chemistry method development LC/MS/MS and GC/MS to address biological problems.

•Metabolomics and Inflammatory Disease Study
•Pharmacokinetics (PK) Study
•Hypertension
•Analytical Method Development

Currently, I am working as a Technical Manager in Research and Development division at Dionex Corporation, Sunnyvale, CA. I joined Dionex in 2003 and actively involved with the bioanalytical column and application development. Earlier, I worked as a senior scientist at Pharmagenesis, a Palo Alto based Biotech Company that was engaged in new drug discovery and development 20012003. During this time I worked on the drugtarget interactions and elucidation of the mechanism of action of the drugs. I started my post doc life at the Laboratory of Biochemistry, Department of Biology, NYU with Prof. Peter Coleman. My research was focused on Isoprenoids, cholesterol biosynthesis and cell proliferation. Following this, I worked as a research associate and instructor with Prof. Susan Horwitz, Cochair, Department of Molecular pharmacology at the Albert Einstein College of Medicine 19901995; 19982001. I worked on Taxoltubulin interactions and mapped taxol binding sites on tubulin. Also, I worked as a group leader in the New Drug Discovery Division at Ranbaxy Laboratories Ltd., New Delhi, India 199698. I obtained my PhD from the Department of Biochemistry, Osmania University, Hyderabad, India.

•Developing new Analytical techniques for bio-molecule qualitative and quantitative analysis
•Monoclonal antibodies usage in cancer treatment
•Monoclonal antibody analysis and heterogeneity characterization by chromatography.
• HPLC method development using different stationary phases and various column chemistries for protein and monoclonal antibody analysis
• Cancer drug target discovery and development by employing intelligent analytical methodology
•Development of new analytical methods for applied research

Dr. Adamec received his PhD at the Institute of Microbiology of the Czech Academy of Sciences in 1994. From 1995 he spent several years at Yale University and Mayo Clinic as a postdoctoral fellow working on the problems of metabolic disease. From 2004 to 2010, he was a Lead Scientist and a Director of Proteomics and Metabolomics Core Facilities at Bindley Bioscience Center at Purdue University. In summer 2010, he joined the faculty of University of Nebraska – Lincoln where he currently holds the position of an Associate Professor at Department of Biochemistry.

Major interests: Oxidative stress, cancer biology, identification of biological makers, elucidation of the impact of drugs on cells/organisms and development new technologies for proteomics and metabolomics.

 After earning PhD, Gordon A Awandare worked with Dr. Jose Stoute as a post-doctoral fellow at the Walter Reed Army Institute of Research , MD, where he investigated novel red cell surface receptors used by Plasmodium falciparum parasites for sialic-acid-independent invasion. During that time at WRAIR, he was part of the team that identified CR1 as the major receptor used by P. falciparum parasites for sialic-acid independent invasion of red cells.

Gordon A Awandare research focuses on the pathogenesis of Plasmodium falciparum malaria in children. He has been investigating the production of inflammatory mediators and the relationship between genetic variation in innate immune response genes and susceptibility to severe malaria in children. His research on the Plasmodium parasite is aimed at gaining a better understanding of the mechanisms used for invasion of red blood cells. Therefore, a substantial aspect of his research efforts focus on characterizing the sialic acid-independent pathways of invasion and identifying novel receptors and ligands involved.

Toth is an Assistant Professor in the Department of Biochemistry and Molecular Biology at the University of Maryland, Baltimore. Dr. Toth received his bachelor’s degree in Biochemistry with honors from the University of Pennsylvania in 1992. Dr. Toth undertook graduate studies at the University of California, Los Angeles and received a doctorate in Biochemistry in 1999 for his structural studies of adenylosuccinate lyases. Dr. Toth continued his research in the Department of Chemistry and Biochemistry at UCLA as a postdoctoral research associate from 1999-2000. Subsequently, Dr. Toth did postdoctoral research at Harvard Medical School from 2000 to 2004, where he studied the structure and function of replicative helicases and lesion-bypass polymerases. Dr. Toth was supported by NIH fellowships during both his doctoral and postdoctoral studies. Dr. Toth assumed his current position at the University of Maryland, Baltimore in 2004.

Eric A. Toth research centers on the structure and function of protein complexes crucial to chromosomal integrity and RNA processing.

Scorei Ion Romulus research interests are Origin of life study prebiotic chemistry of Boron, Information concerning my origin of life research, Working in area of Low Resolution Nuclear Magnetic Resonance, Pulse Technique, Biology and animal nutrition.

Livia Visai is presently a Lecturer in Chemistry and Biochemistry and a Research Assistant in Biochemistry at the Medicine Faculty of the University of Pavia.
Dr Visai received her degree in Biology at the University of Pavia in 1985 discussing a thesis entitled A study of the collagens interaction with hepatocytes and bacteria. In 1985-1987, She had been working at the Connective Tissue Laboratory, Department of Bochemistry at University of Alabama in Birmingham, USA, where her research interest was focused to studying the mechanisms of bacterial adhesion to extracellular matrix proteins. In 1989, L.V. received a Ph.D in Biochemistry at the Biochemistry Department of Pavias University discussing a thesis entitled A study of the interactions of collagens with strains of S.aureus Cowan 1 and E.coli B34289c. In 1989-1990, She received a fellowship at University of Pavia and in 1991-1992 She was trained as Post-Doctoral fellow in Biochemistry. In 1992 She received the Title of "European Biologist" from the Biologist Association of the European Community. In 1994 She obtained a position of Research Assistant in Biochemistry at the University of Pavia, Medical School. Since 1997 She is a Lecturer in Biochemistry and Chemistry at the Medicine Faculty and at the InterFaculty of Biotechnology in Pavia University. In 2001 and 2009, Dr Visai spent few months in the Center for Extracellular Matrix Biology at the Institute of Bioscences and Technology of the Texas A&M University System Health Science Center in Houston to complete a project involving the characterization of the binding of bacterial adhesins to fibronectin and collagen.

Her main scientific interests involve analysis of the immunological and biochemical properties of bacterial adhesins for components of the extracellular matrix proteins. Recently, She has focused her research interest to study the interaction of various biomaterials and 3D scaffolds such as polyurethanes and titanium foams with cells such as mesenchymal stem cells, adipose stem cells, osteoblasts, fibroblasts, platelets and macrophages. She is also involved in studying novel treatments for biomaterial surface modifications that are quite important to improve cell-material interactions and to reduce bacterial adhesion.
In 2006, Dr Visai has created a Center for Tissue Engineering CIT, whose research project was funded in 2007 FIRB at University of Pavia. She is vice-director of CIT.

Nilgun Tekkesin has recieved M.D. from Uludağ University during the period of 1986 - 1992. She started biochemistry specialist carrier at Marmara University. Her doctoral thesis entitled Role of HGF and VEGF in hepatic regeneration after hepatoxin-induced cirrhosis and partial hepatectomy in mice was completed under the direction of Prof. Dr. Yavuz Taga, and got ICCC Kyoto Awards in 2002. She followed her post-doc training as an assistant proffesor of clinical biochemistry in Yeditepe University. Currently, She is the chief of the department of laboratory medicine at Şişli Memorial Hospital, Turkey. I am the medical director of Transfusion Medicine at Ataşehir Memorial Hospital, Turkey. I have authored and co-authored many researched articles. I have presented my researches at national and international congress. I’m a member of Society of Free Radical Research, Turkish Biochemical Society, Turkish Biochemical Specialists Society and IASGO.

Nilgun Tekkesin main areas of research are quality in laboratory medicine, biomarkers in cancer and cardiovascular diseases, in blood coagulation and in hepatocelluler regeneration. She continued my awarded experimental studies in liver regeneration. The hospital is one of the main centre in liver regeneration and this creates new opportunities for me to work on liver, broadly. She dealed with errors in a hospital laboratory and patient safety. Especially, preanalytical errors in coagulation tests causing inapprociate results are the main errors in our laboratory besides many laboratories. The major research interests of her laboratory are to develop preventive medicine programs through clinical biochemistry research and the related basic and application research. Human epididymis protein 4 is one of the novel diagnostic and prognostic marker in ovarian cancers and has a great value combined with CA 125 (ROMA). She study this marker in a routine order in my laboratory and this is the first in Turkey. She improved the unneccesary usage of  so many blood transfusions in transplatation surgery by using thromboelastograph.

Dr. Mingxuan Xu received her Ph.D. from Chinese Academy of Science in Microbiology, During her Ph.D, her research mainly focus on functional studies of linear plasmid SLP2 in Streptomyce livindance, the mechanism that maintain SLP2 replication as linear mode and the conjugation of linear plasmid. Dr. Mingxuan Xu then switched her research field to neuroscience during her postdoctoral training at the Ohio State University on studies of Voltage gated potassium channel Kv3.1 trafficking . Axonal targeting of Kv3.1 is associated with adaptor protein Ankyrin G and motor protein KIF5B, Differential Axonal/dendritic targeting of two Kv3.1 isoforms Kv3.1a and Kv3.1b is due to preferentially association with AnkG and Kv3.1 self- inhibition mediated by N-terminus and C-terminus interaction.

Dr. Mingxuan Xu current research aims is to study how the KCNQ channels regulate excitability by being concentrated at axon initial segments and nodes of Ranvier. KCNQ channels are targets of antiepileptic drugs and are mutated in a human epilepsy syndrome called Benign Familial Neonatal Seizures. This research could lead to new understanding of epilepsy mechanisms and better treatments for epilepsy and related disorders.
 

Dr. Yong Wu has received his doctoral degree & Master degree from Department of Pathophysiology, Medical College of Wuhan University. He successfully completed responsibilities as Postdoctoral Fellow from University of Oklahoma Health Science Center (2005-2008) & University of California (2008-2010). Currently Dr, Yong Wu working as Professional Researcher, Department of Biochemistry, University of California.

1) Pathogenesis of insulin resistance and type 2 diabetes
2) Molecular investigation of the pathogenesis of obesity and diabetes
3) Lipid metabolism and signaling transduction
4) Molecular and cellular biology of cardiovascular diseases
5) Nitric oxidative (NO) and reactive oxygen species (ROS) signaling in endothelial
cell
6) Cancer and metabolism

During the PhD with Prof. Michael Wegner in Erlangen (D), she studied the function of the transcription factor Sox8 in mouse development. From there, she went on to study the role of metabolism in skeletal patterning in Prof. Cheryll Tickle’s lab in Dundee (UK); in particular, she investigated ER-resident cytochrome P450 enzymes in the mouse. Driven by the hypothesis that there would be a link between P450s and secretion, she joined Prof. David Stephens’ lab in Bristol to expand my knowledge in the cell biology and biochemistry of ER-to-Golgi traffic. The experience in electron microscopy gained there has now led me to the University of Utrecht (NL) where I am working on the ultrastructural aspects of secondary modification and secretion of therapeutic proteins in the group of Prof. Dirk Bosch. Acquired data along the way have led to various publications and conference talks.

The overall aim is to combine the experience in model organisms, cell biology and metabolism / biochemistry. Katy Schmidt research interest and the underlying motivation are to understand disease mechanisms in congenital and acquired human diseases, particularly their biochemical consequences in a more physiologically relevant context. Working towards this end would hopefully have medical and translational consequences in terms of improved tissue engineering with the additional long-term aim to identify of potential drug targets in e.g. membrane traffic or also metabolic pathways.

Prof. Bechan Sharma has received his PhD in Biochemistry from Banaras HinduUniversity -Varanasi, India during the period of 1988. Currently, he is working as a Professor of Biochemistry in University of Allahabad, Allahabad-India. He has successfully completed his Administrative responsibilities as a Chairman, Biochemistry Department. He is serving as an Chief Editor/Associate Editor/Editorial member of several reputed journals like Cellular and Molecular Biology -France, International J. Pharmacy and Pharmacological Research, Journal of Environmental and Occupational Medicine (JEOM), China, Journal of Eco-Physiology and Occupational Health (JEOH), India, Int. J. Antivirals & Antiretrovirals (Omics Publishing Group),USA, and 17 other international journals. He has authored more than 90. research articles/books. He is a member of American Association for the Advancement of Science, USA, Society of Biological Chemists, India, Indian Science Congress Association, India, International Forum for Public Health, Shanghai, China and three other National Scientific Societies in India. He has been honored with many National and International Awards.

Prof. Bechan Sharma research interests are Molecular Biology of HIV-1, Biochemistry and Biochemical Toxicology.

Dr Adie Viljoen is a clinical specialist and works as Consultant Chemical Pathologist and Metabolic Physician in Hertfordshire, UK since 2006 having trained in South Africa where he received his medical and speciality medicine qualifications.He is Senior Lecturer in Medicine at the Bedfordshire and Hertfordshire Postgraduate Medical and Member of the Institute for Diabetes in Older People (IDOP).He is the UK Chief Investigator and Principal Site investigator for several international phase 2 and 3 research trials in diabetes, obesity and lipids including studies such as EXAMINE, ORIGIN, 4T, CRESCENDO. He is a member of the Scientific Research Committee of HEART UK, the UK cholesterol charity. He has authored more than 50 peer reviewed scientific publications and 5 book chapters. He serves on the editorial board of several medical journals including Clinical Vascular Pharmacology.

Dr. Adie Viljoen conducts clinics in diabetes, cardiovascular risk prevention, lipid and metabolic disorders. His interests include type 2 diabetes and diabetic dyslipidaemia, diabetes and lipid management in the older person as well as the laboratory analysis of lipoproteins and hormones.
 

Dr. Kamal Adel Amin is an Associate Professor of Biochemistry, Head Department of Biochemistry, Faculty of Veterinary Medicine, Beni-Suef, University.

Our research involve; Obesity and associated disorder, its mechanism and treatment. Metabolic syndrome- food additives and its effect on the body organs.
We aim to study the role of biochemical markers, oxidative markers, nitric oxide, and inflammatory marker in obesity, hepatotoxicity and other organ affection.

Dr. M. Salman Khan has received my Ph.D. in Medical Biochemistry from Aligarh Muslim University, Aligarh, INDIA in Dec’2008. Currently he is working as Assistant Professor, Department of Biotechnology in Integral University. He is serving as an editorial member of several reputed journals like International Journal of Pharmaceutical Analysis and Journal of Bioscience and Medicine. He has authored more than seven research articles in international journals and currently also working as a reviewer for several international journals.

Presently I am working to find out the possible mechanism of role of natural products and their bioactive compounds in combating various free radical mediated diseases including atherosclerosis, hyperlipidemia and diabetes in animal and human models. In addition, I am also working on mechanistic aspect of drug interaction with key enzymes/proteins in above disease models and to develop new analogues with the use of bioinformatics.

Georges Nemer has received his PhD in pharmacology from the University of Montreal in 2002. Currently he is working as Assoicate Professor in the department of biochemistry and molecular genetics at the American University of Beirut. He is responsible of the molecular core facility at the faculty of medicine since 2002, and member of both the Research committee at the faculty as well as the IRB. He is currently serving as an editorial member of the Open Journal of Genetics. He has authored more than 30 research articles/books.

Georges Nemer research interests are clinical to basic sciences,genetics of congenital heart disease (CHD),regulation of gene expression, mutations, molecular mechanisms involved in heart malformations, transcription factors and other genetic studies.

Dr. Hengye Man received his MD from Taishan Medical College in 1986 and Ph.D. from Toronto University in 2001. He then worked at the Department of Neuroscience, Johns Hopkins University as a postdoctoral fellow until he was recruited by Boston University Biology Department as an Assistant Professor in 2005. Dr. Man’s research focuses on the regulation of glutamate receptor trafficking and turnover, and its role in synaptic plasticity including long-term potentiation and depression, as well as homeostatic synaptic regulation. He also investigates axon growth and neuronal polarization. He has authored and co-authors primary research articles in journals including Nature, Science, Cell, Neuron, J Neuroscience and PNAS.

 Dr. Man’s research focuses on the regulation of glutamate receptor trafficking and turnover, and its role in synaptic plasticity including long-term potentiation and depression, as well as homeostatic synaptic regulation. He also investigates axon growth and neuronal polarization.

Aurelia Magdalena Pisoschi was born in Bucharest, Romania, on the 6th of October, 1976. She graduated in June 1999 and got her Degree in Organic Chemistry at the Faculty of Chemistry of the University of Bucharest. In 2001, She received the M.S. Degree in Organic Chemistry and Physical Chemistry. She got Ph.D. Degree at the Analytical Chemistry Department of the Faculty of Chemistry of the University of Bucharest in December 2009 & the PhD Thesis entitled "Analytical control methods of some food products’ quality” deals with the application of analytical methods based on electrochemical biosensors and voltammetry in the assessment of some components of foodstuffs. She work as an Assistant Professor at the Faculty of Veterinary Medicine of the University of Agronomic Sciences and Veterinary Medicine of Bucharest, in the fields Chemistry and Biochemistry. Starting with March 2011, She began teaching a course on Food Additives and Ingredients. Presently, I also work as a postdoctoral researcher in the frame of a European POSDRU Project. In 2010 and 2011, She collaborated as reviewer with the journals Talanta and Journal of Electroanalytical Chemistry. She published several research articles in ISI Web of Knowledge (ISI Web of Science and ISI Master Journal List) classified journals.

Aurelia Magdalena Pisoschi research interest is represented by Electroanalytical and Spectrometrical Methods: electrochemical (amperometric and potentiometric) enzyme sensors, voltammetry (differential pulse voltammetry and cyclic voltammetry), biamperometry based on the redox couple DPPH?/DPPH, UV-VIS spectrometry. These methods were used in the determination of several key compounds present in foodstuffs like sugars (glucose) and vitamins (ascorbic acid) and of the total antioxidant capacity.

Prof. Xuping Sun has received his PhD in Analytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China. Currently, he is working as Professor, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China & Adjunct Professor, Chemistry Department and Center of Excellence for Advanced MaterialsResearch, King Abdulaziz University, Saudi Arabia. He is serving as an editorial member of American Journal of Nanotechnology. He has published over 140 research papers.

Prof. Xuping Sun is working on bionanotechnology and functional materials. Currently, his research interests have been focused on (1) Nanoelectrochemistry; (2) DNA nanotechnology; (3) Biochip; (4) Nanomedicine; (5) Supramolecular chemistry; (6) Materials chemistry; (7) Photocatalysis and photoelectrochemistry.

Xiuqing Yang is an Associate professor in the Institute of Biotechnology at Shanxi University. He has received his Ph.D. from Chinese Academy of Science in Microbiology. He has authored 25 research articles and worked as a reviewer of Environmental Science Technology and Biochemical Engineering journal.

Dr Yang’s research focuses on the function genes, regulation of gene expression and enzyme kinetics of environmental microbiology.

Noboru Sato is an Assistant Professor of Biochemistry at University of California, Riverside. After receiving M.D. and Ph.D. degree in Japan, he started his research career focusing on the biological roles of specific signaling pathways at Weill (formerly known as Cornell) Medical College in New York. He then became interested in human embryonic stem cell research in 2000 and developed new research directions focusing on the molecular regulation of pluripotency at Memorial Sloan-Kettering Cancer Center and The Rockefeller University. As an independent researcher at UCR, he continues to study how pluripotency is regulated at the signaling level using human embryonic and induced pluripotent stem cells as model systems.  

We are investigating how the function (self-renewal and pluripotency) and structure (cell architecture and cell-cell interactions) of pluripotent stem cells are mutually integrated to establish their unique molecular identity. We have determined that non-muscle myosin II (NMII) plays an essential role for the regulation of cellular interaction machineries in human and mouse ES cells, and is placed downstream of Rho-Rock signaling (Harb et al. 2008). Recently, we have reported that NMII is a key molecule which regulates cell survival of human pluripotent stem cells (Walker et al. 2010). We are currently focusing on understanding how NMII signaling and self-renewal regulators are interacting each other to determine the unique biological nature of human pluripotent stem cells.

 Prof. Walter Filgueira de Azevedo Junior received his Ph.D in Science at State University of Sao Paulo (Brazil) in 1997. He worked as visiting researcher at University of California (USA) from 1993 to 1996, under supervision of Prof. Sung Hou-Kim. During my PhD he solved several crystallographic structures of CDK2 in complex with ligands. He has supervised 7 PhD theses in the fields of protein crystallography and bioinformatics and published over 140 scientific articles. I am editor of Current Drug Targets (ISSN 1389-4501) and guest editor of Current Medicinal Chemistry and referee for several scientific journals, such as, Current Bioinformatics, Bioinformatics, and Current Drug Targets.

My research is focused on intermolecular interactions and bio-inspired computing, protein structures, drug design, and bioinformatics.. I aim to pursue fundamental research in protein-drug interactions and correlate these results with experimental ones. To achieve our goals I make use of biological crystallography, molecular dynamics, molecular docking, quantitative-structure activity relationship (QSAR) and several computational methods to address the problem of protein-drug interactions. In addition, I am also developing computational tools, based on bio-inspired computing. Examples of these computational tools include evolutionary algorithms, artificial neural networks, DNA computing, and swarm intelligence.

Mohammad-Reza Rashidi is a professor of medicinal chemistry at Tabriz University of Medical Sciences (TUOMS) at School of Pharmacy. He studied pharmacy at Tabriz School of Pharmacy (TUOMS) and gained his PhD in drug metabolism from Bradford University (UK) in 1996. During his PhD study, he received Oversea Research Scholarship (ORS) for three successive years. He has also received National Razi Award for excellence in research in pharmaceutical sciences in 2010. In 1998, he founded Drug Applied Research Center and worked at that center as the Director for 4 years before taking up his appointment as Director of International Relations Office of TUOMS. Then, he was appointed as Vice-Chancellor for Research and Technology of TUOMS. Dr Rashidi has published more than 70 original research papers in peer-reviewed journals.

Mohammad-Reza Rashidi research intere role of some enzymatic systems in drug metabolism, Investigation of structure/activity relationships for substrates and inhibitors of molybdenum hydroxylases, The effects of natural products on molybdenum hydroxylases activity and reactive oxygen species generation, Instrumental analysis of endogenous and exogenous compounds in biological samples, Application of chemometric methods in enzymology.

Dr. Veronika Doubnerová is an Assistant Professor in the Department of Biochemistry at the Faculty of Natural Science of Charles University in Prague. She has received her Ph.D. degree in Biochemistry at the same University in 2008. The Ph.D. thesis entitled “Study of the regulation of NADP-malic enzyme (decarboxylating) and influence of stress on this enzyme” deals with plant enzyme, which gain more importance under stress conditions, especially in conditions of biotic stress caused by strains of Potato virus Y and in conditions of abiotic stress in form of drought or low CO2 availability. Presently, she continues in the research of various plant enzymes, which are involved in plant stress response. She participates in lecture Plant Biochemistry and in Practical Biochemical Courses. She is a member of FEBS and IUBMB.

Dr. Veronika Doubnerová research interests are Metabolic changes in plants under stress conditions, Enzyme kinetics and inhibition studies, NADP-dependent enzymes.

Dr.Xiaoli Gao has received her PhD in Genetics from Michigan State University during the period of 2005- 2009. Currently, she is working as Research Associate in Pacific Northwest National Lab. she is a member of American Society for Mass Spectrometry (ASMS), American Chemical Society (ACS), American Association of Pharmaceutical Scientists (AAPS) and Sigma-Xi membership.

Xiaoli Gao Research Focused on Biochemistry, Analytical Chemistry, Mass Spectrometry, GC-MS, LC-MS, Metabolomics, and Proteomics.

Prof/Dr Jagat R. Kanwar has received his PhD in 1992 from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Before joining Deakin University, Australia, in 2006, he was a Senior Scientist in the University of Auckland, Auckland, New Zealand. Dr Kanwar, group leader of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research has a national and international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. Currently, his major field if interest are nanomedicine based delivery systems for therapy/diagnosis, biotechnology, protein engineering of therapeutic proteins and find their mechanism of actions. He has successfully completed his Administrative responsibilities as Head of Nanomedicine in the Centre for Biotechnology and Interdisciplinary Biosciences (BioDeakin), Institute for Technology & Research Innovation (ITRI), Deakin University. He is serving as an editorial member of several reputed journals in the field of Biochemistry, Nanobiotechnology, Nanomedicine, Cancer and Immunology. He has authored more than 85 research articles, 12 book chapters and 2 books, and secured more than 10 patents. He is the Member of Editorial Board for 12 international journals and a nominated member of more than 18 national and international societies including American Nano Society and American Society of Nanomedicine.

Prof/Dr Jagat R. Kanwar has received his PhD in 1992 from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Before joining Deakin University, Australia, in 2006, he was a Senior Scientist in the University of Auckland, Auckland, New Zealand. Dr Kanwar, group leader of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research has a national and international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. Currently, his major field if interest are nanomedicine based delivery systems for therapy/diagnosis, biotechnology, protein engineering of therapeutic proteins and find their mechanism of actions. He has successfully completed his Administrative responsibilities as Head of Nanomedicine in the Centre for Biotechnology and Interdisciplinary Biosciences (BioDeakin), Institute for Technology & Research Innovation (ITRI), Deakin University. He is serving as an editorial member of several reputed journals in the field of Biochemistry, Nanobiotechnology, Nanomedicine, Cancer and Immunology. He has authored more than 85 research articles, 12 book chapters and 2 books, and secured more than 10 patents. He is the Member of Editorial Board for 12 international journals and a nominated member of more than 18 national and international societies including American Nano Society and American Society of Nanomedicine.

Dr. Marcy Hernick is currently an Assistant Professor in the Biochemistry Department at Virginia Tech. Dr. Hernick received her B.S. in Pharmacy from Albany College of Pharmacy in Albany, NY in 1998. She earned her Ph. D in Medicinal Chemistry from Purdue University, Department of Medicinal Chemistry and Molecular Pharmacology in 2002 for her work on the design, synthesis, mechanisms of activation and biological activity of indoloquinone phosphoramidate prodrugs. Dr. Hernick completed her postdoctoral studies at the University of Michigan Chemistry Department, where she studied the enzyme mechanism and molecular recognition properties of the metalloenzyme LpxC deacetylase. Dr. Hernick assumed her current position at Virginia Tech in 2007.

My research is focused on the characterization of enzymes involved in the biosynthesis of inositol-containing compounds. Specifically, the work in my laboratory is centered on two metabolites: inositol and mycothiol. Inositol is small (sugar) molecule present in both eukaryotes and prokaryotes that serves as an important signaling molecule, component of cellular membranes and as an important component of other essential small molecules (e.g. mycothiol). Mycothiol is a specialized inositol-containing molecule that is synthesized by mycobacteria and serves essential functions in these organisms by protecting against oxidative damage and detoxifying drugs and other toxins that enter the bacteria. Due to the important functions that these molecules serve, the enzymes that are used to make them are targets for drug development. Consequently, our long-term goal is to use information we gain about the structure and function of the enzymes that make these small molecules to design inhibitors with the potential to serve as therapeutic agents for the treatment of infectious diseases.

 Gabor Szabo is working as assistant professor in Semmelweis University. He has successfully completed his Administrative responsibilities as Obstetrician and Gynecologyst. He has authored 8 research articles. He is a member of the European Society of Human Genetics, Hungarian Society of Obstetrics and Gynecology, Hungarian Society of Ultrasound in Obstetrics and Gynecology, Hungarian Society of Obstetrical and Perinatal Anaesthesiology, Hungarian Society of Hypertonology.

Gabor Szabo research interests are Pre-eclampsia, Pathological Pregnancies, Hypertension, Gene polymorphism

Dr. Monica Butnariu has received his PhD from Banat’s University of Agricultural Sciences and Veterinary Medicine, Timisoara University & Postdoctoral Studies from Transylvania University. Currently, she is working as Associate Professor in Department of Chemistry and Vegetal Biochemistry, Banat’s University University, Greese. She is serving as an editorial member of International Journal of Agricultural Chemistry. She has authored 6 books. She is a member of Society of Biochemistry and Molecular Biology, International Society of Environmental Bio indicators.

Dr. Monica Butnariu Research Interests are Chemistry and Analytical Biochemistry Research on natural compounds or active principles of plants Heavy metals accumulation mechanisms in plant and the absorption and translocation of different growth compounds by plants Analytical research for quantification of chemical and biological parameters using biomarkers.

She is a consultant biochemist at the department of Clinical Biochemistry and she is co-director of the Central laboratory of the Medical Faculty of Cukurova University, Balcali Hospital, Adana, Turkey. Her particular interests include the cost-effective utilization of laboratory medicine as well as the reduction of analytical and non-analytical sources of error. She is also involved in the clinical interpretation of routine laboratory tests (chemistry, hematology, coagulation, blood gas, toxicology, molecular and immunological tests).Her recent studies were about transplantation immunology especially, detecting and quantifying the IgG subclass composition of HLA alloantibodies and to evaluate the risk of antibody mediated rejection in kidney transplants. In addition, she is interested in molecular tumor diagnostics and tumor immunogenetics.

Her particular interests include the cost-effective utilization of laboratory medicine as well as the reduction of analytical and non-analytical sources of error. She is also involved in the clinical interpretation of routine laboratory tests (chemistry, hematology, coagulation, blood gas, toxicology, molecular and immunological tests).

Dr Amineni Umamaheswari has received her PhD from Sri Krishnadevaraya University, India in the year, 1998. Currently, she is working as Associate Professor in Sri Venkateswara Institute of Medical Sciences University, Tirupati, India. She is heading the Department of Bioinformatics and acting as the Coordinator of Bioinformatics Infrastructure Facility sponsored by Department of Biotechnology, Ministry of Science and Technology Govt. of India, New Delhi. She is serving as an Advisory editorial committee member of Journal of Bioscience and medicine and reviewer of reputed journals like Chemical Biology and Drug Design, Indian Journal of Biotechnology, African Journal of Biotechnology etc. She has authored 20 research articles and 42 abstracts. She was honoured with certificate of appreciation in Centenary International womens’ Day celebrations, 2011 organized on 8/03/2011 at SVIMS University, Tirupati and was awarded with Merit Certificate of Appreciation on the occasion of Republic Day, 2010 by the Director, SVIMS.

Her research focus is on implementing computer aided drug designing and reverse vaccinology approaches to identify potential drug molecules and vaccine candidates, respectively, against various bacterial pathogens. She has been using Molecular modelling, high throughput virtual screening, fragment based screening, QSAR analysis, pharmacophore modelling to propose potential inhibitors against several drug targets. Comparative and pan-genome reverse vaccinology method was implemented successfully to propose common epitope driven vaccines against several bacterial pathogens.

Dr Rajesh Arora is a Scientist and is currently holding the position of Staff Officer in the Office of Distinguished Scientist and Chief Controller Research and Development (Life Sciences and International Cooperation), Defence Research and Development Organization, Government of India. His contributions in the area of novel drug design and development, particularly radiation countermeasure agents of natural (herbal as well as microbial) origin and augmentation of medicinally useful secondary metabolites using biotechnological interventions have received wide acclaim. Dr Arora’s name is included in the Who’s Who of the World, USA, Who’s Who in Science and Engineering, USA and International Biography, UK. In addition, he has been awarded several prestigious fellowships and awards. Recently, he received the DRDO Laboratory Scientist of the Year Award (2010). Dr Arora has been a Visiting Scientist in the European Union during 2009–10. Dr Arora has published extensively in peer reviewed international journals and has 12 patents and 7 books to his credit, including three from Oxon, UK. He is a life member of several professional societies and is on the editorial board of numerous journals. Several of his students occupy responsible positions in the government/academia/industry. Dr Arora received his PhD in Biotechnology jointly from Central Institute of Medicinal and Aromatic Plants, Lucknow, and University of Meerut. He also holds post-graduate diplomas in Human Resource Development and Marketing Management and an MBA degree in Human Resource Management. Dr Arora was professionally trained at the Central Drug Research Institute, Lucknow, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, Defence Institute of Advanced Technology, Pune, Defence Institute of Physiology and Allied Sciences, Delhi, and Institute of Technology Management, Mussoorie. Dr Arora has also been involved in Technical and Human Resource Development activities for leveraging human capital in cutting edge areas of Science and Technology.

Novel drug design and development, particularly radiation countermeasure agents of natural (herbal as well as microbial) origin and augmentation of medicinally useful secondary metabolites using biotechnological interventions,Biotechnology, Radiation Biology, CBRN Defence, Natural Resources.

Dr. Hansen Wang is a Research Scientist in the Faculty of Medicine at the University of Toronto. He received his Ph.D. degree from Shandong University, China. Dr. Wang has been studying the neurobiology of human diseases by using genetic and pharmacological approaches. His research mainly focus on the molecular and cellular mechanisms of neurological disorders, such as Fragile X syndrome, Rett syndrome, neuropathic pain and neurodegenerative diseases. He believes that his research may ultimately help identify therapeutic targets for these neurological disorders. Dr. Wang has published and presented frequently for his basic study of neurological disorders.

Dr. Hansen Wang research interests are Neurobiology of diseases, molecular and cellular mechanisms of neurological disorders, such as Fragile X syndrome, Rett syndrome, neuropathic pain and neurodegenerative diseases.